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South Africa has been in lockdown since 27 March 2020, and the 
government is slowly easing restrictions as part of a risk management 
strategy based on the number of people infected with SARS-CoV-2 
balanced against the need to open up the economy. In parallel with 
the easing of restrictions, the country is experiencing an increase 
in infections with a peak expected in July/August 2020. The initial 
phases of the lockdown were effective in allowing healthcare services 
to become established to prepare for the increase in the number of 
cases expected. Subsequently, a delicate balancing act has ensued, in 
which efforts have been made to ensure the preservation of both life 
and livelihoods. However, as the lockdown is lifted, the numbers of 
infected individuals will increase.
But what about research? A university is a community of teachers 
and scholars, where learning at the highest level is led by the creation 
of new knowledge, and where scholars with different disciplinary 
backgrounds engage to debate and share thought. Research lies at 
the heart of a university. Indeed, the drive to discover, to create 
new knowledge and to impart it is often what motivates university 
researchers to choose academic careers.
Much research activity at universities has been halted by the 
closure of campuses, in support of lockdowns and social distancing. 
Many research programmes, particularly those that are dependent 
on access to laboratories and specialised research facilities, are 
being delayed, postponed or stopped, at least temporarily.[1,2] 
Researchers are isolated, and not able to work in the facilities that 
are essential for their research. Online working does, however, 
lend itself to analysis of existing data, typified by analysis of large 
datasets, so-called ‘big data’, for example in bioinformatics analysis 
of human or other genomes.[3]
Research conducted by universities often involves postgraduate 
students who have defined time periods in which to conduct the 
research components of their higher degrees, and time away from 
research facilities is time lost in terms of the completion of their 
degrees. Time is also lost in meeting research milestones, and a 
strategy is needed to allow for the resumption of research activities 
and regaining of momentum.
The recent redirection of national and international resources 
to address COVID-19 will mean that less funding will be available 
for other projects, and it will be necessary to select and prioritise 
research activities. Research under these circumstances will mainly 
be purpose-driven, and the availability of funding for so-called ‘blue 
skies’ research is likely to be limited for some time to come.[4]
Once lockdowns are (at least partially) lifted and new arrangements 
are made to enable research to resume, research activities will gradually 
begin to approach the ‘norm’ as occurred before the pandemic. 
Nowhere is the dictum that opportunity arises in situations of adversity 
more applicable, and this is an opportunity to ask ourselves what was 
working well, what was not working, and how we can create a more 
efficient, relevant and productive research environment.
Resuming research activity
In the short term, it is critical that researchers return to their 
campuses to restart or resume research programmes before they are 
no longer redeemable. The key activities include experimental work 
to generate or gather data, and the co-ordinated operational actions 
needed to address restarting laboratories, regaining the necessary 
levels of productivity, and making up for lost time. Restarting some 
experiments may prove to be very challenging – biological materials 
may no longer be viable, animal lines may be expensive to replace, 
instruments may malfunction, and supplies are likely to be slow to be 
delivered as suppliers respond to a wave of orders.[2]
Laboratory safety and efficiency will now have additional elements 
to be considered.[2,5] Social distancing will remain with us for some 
time, and this will mean establishing new ways of accessing and 
working in research venues, managing research time more flexibly, 
limiting the numbers of researchers in laboratories, and managing 
the use, and planning the maintenance, of common instrumentation 
facilities and platforms differently.
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Improving on research approaches
In the medium term, we should ask ourselves what we have learned 
from COVID-19, and what we should do differently. Many aspects 
need to be considered, and three examples stand out.
First, the past few months have shown us that the previously 
long time periods taken to produce and publish a research article 
can be – and have been – significantly reduced.[6] This is not to say 
that we should compromise on quality and devalue excellence. We 
continue to strive to achieve research excellence because we believe 
that through excellent research, we can influence the transformations 
needed by our country, our continent, and the world.
Many COVID-19 publications have been made freely available 
online, a recognition by the global research community that open-
access publishing promotes access to valuable information that in 
turn could lead to the more rapid development of solutions for urgent 
problems.[7,8]
The COVID-19 pandemic has created pressure on researchers to 
work more rapidly, and to conduct research and clinical trials under 
exceptional urgency, which could lead to the risk of compromising 
rigour and research integrity. The recent retraction of articles 
published in the top-tier medical journals Lancet and New England 
Journal of Medicine, of which the former had a major influence on 
national (UK) and international (World Health Organization) policy, 
highlights the pitfalls that await us and the need for ‘more speed and 
less haste’.[6,9]
Despite the pressures imposed by the scale of the pandemic, 
research methodologies must be rigorous, analyses must be 
conducted with integrity, and clinical trials must be complete as well 
as feasible, whether related to drug design or vaccine development. 
If trials are not comprehensive, and therapies are applied based on 
incomplete information, the negative impact could be dangerous 
and far-reaching.[10] For example, clinicians may, under pressure, 
find themselves making choices to use new treatments based on 
responsibility of care before there has been time to ensure the rigour 
of the research underpinning the development of the therapy.
Second, researchers need to establish better ways to ensure trusted 
communication with the public. We need to publish to ensure that 
society understands our research results and their benefits – and we 
need to make sure that in publishing our research we do so clearly, 
accurately and honestly. To paraphrase a well-known quotation, we 
write to be understood, but perhaps more importantly, we must write 
in a manner which ensures that we are not misunderstood.
The danger lies not only in the academically unethical practice 
of publishing unreliable results, which amounts to disingenuous 
misrepresentation,[11] but, perhaps more seriously, in misleading the 
(possibly naive) reader with unfounded assertions that he or she may 
then act upon – with a multitude of possible consequences.[12]
Third, at the core of finding solutions to the COVID-19 pandemic 
is the recognition that no single discipline can resolve all the 
problems that have arisen. Inter- and trans-disciplinary collaboration, 
partnerships, and social responsibility are key to a successful outcome. 
The scientific and medical professions must be complemented by the 
economic and legal professions, and human rights must be ensured, 
particularly when systems are overloaded and attention to detail may 
be compromised.
Research priorities
In the longer term, we need to define research priorities. While 
many of the current research efforts globally are justifiably being 
re-focused on COVID-19, decisions will need to made about research 
in other areas.[13] COVID-19 is likely to be with us for some time 
to come, and the likelihood of other pandemics occurring will 
increase with time. However, other diseases, both communicable and 
non-communicable, will not diminish, and our attention must not 
be diverted from addressing these diseases, many of which render 
individuals more susceptible to poor outcomes in the context of 
COVID-19 (hypertension, diabetes, heart disease).
There is little doubt that at present the focus on understanding 
COVID-19, and the search for vaccines and treatment regimens, 
should be at the forefront. Since January 2020, globally, close to 10 000 
publications and reports have been published on the virus and its 
impact, and it is admirable that such rapid progress has been made;[14] as 
we wrote this commentary, the first vaccine was going to human trials 
in the UK,[15] and the first results of mesenchymal stem cell therapy 
for COVID-19 were being reported.[16] In developing the vaccine, the 
next steps will involve the combined efforts not only of biomedical 
researchers, molecular biologists and virologists, but also biochemical 
engineers and industrial pharma production companies. The world is 
waiting for an effective vaccine to be produced, in sufficient quantities 
and in record time, to enable return to a freer way of life.
Should all our future research be directed towards solving immediate 
and current challenges? In saying that it should not, we should consider 
the importance of fundamental research. The research that is currently 
addressing the COVID-19 pandemic is underpinned by decades of 
forward-looking blue skies (fundamental) research that was thought 
about, designed and carried out by researchers who had creative ideas, 
and developed new theories and new technologies, long before they 
could have predicted their use, in 2020, to manage a world in crisis. 
We cannot afford to ignore, or under-resource, fundamental research.
Furthermore, we need to understand, and contribute to, science 
policy. At all levels, from individual groups to global organisations, 
policy drives the use of resources and steers development. In urgently 
seeking solutions on how to address the COVID-19 pandemic, 
we have seen governments looking to scientists for evidence-based 
recommendations and advice that has directed national and global 
responses and policies. It is up to us as scientists to provide sound 
advice.
In the longer term, the overarching global agenda of achieving 
the Sustainable Development Goals (SDGs) remains relevant and 
important. It may be said that had we made more progress with 
achieving some of the SDGs, the impact of the COVID-19 pandemic 
could have been lessened. For example, food security has not been 
assured in some parts of the world, and had this been adequately 
addressed, the impact of COVID-19 on the number of people 
suffering acute hunger might have been reduced.[17]
One further lesson relates to research co-operation. There has 
been an unprecedented move towards unfettered collaboration and 
co-operation. Conventionally, researchers work in an environment 
where competition is as much a feature of life as is collaboration, but 
the COVID-19 crisis has galvanised a comprehensive joint global 
effort. Teams from leading research organisations around the world 
are collaborating in the search for vaccines, treatments and solutions 
to the health, economic and social crises caused by COVID-19. From 
free sharing of new data on the SARS-CoV-2 genome to design of 
low-cost equipment and development of rapid test kits, researchers 
and organisations in developed and developing countries have been 
co-operating to collectively meet the challenges presented by the 
pandemic.[18] Such collaboration will have allowed some developing 
countries to prepare far more effectively for the pandemic than they 
would have done independently.[19]
As we consider the future of research in COVID-19 times and 
beyond, we should do so in the context of the information era. We have 
for some years seen this as a digitally connected and information-driven 
world, but in this pandemic, with sweeping lockdowns and extreme 
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isolation measures, the relevance of information and data sharing has 
been dramatically brought to the fore. The world has shown what can 
be achieved through virtual information sharing and interactions, and 
the so-called new normal will undoubtedly include the replacement of 
traditional localised modes of communicating and collaborating, for 
instance through conferences, with virtual interactions conducted with 
vast networks, in real time, across the world.
Acquiring and storing research data will become increasingly 
important, but even more so will the ethical issues surrounding access 
to data and particularly personal information. As artificial intelligence 
becomes increasingly effective, we will need to conceptualise ethical 
use of information in different ways. One example is the use of 
cellphone data for tracing contacts of individuals infected with 
COVID-19.[20]
Finally, we need to re-examine the ways in which we train 
students for research through the globally accepted system of 
higher degrees. Postgraduate supervision is a key part of research 
at universities, and postgraduate students often play major roles in 
research programmes. Their research training frequently requires 
that they are the generators of data, and that they spend considerable 
time – usually years – conducting projects through which they are 
expected to create new knowledge and individually make an original 
contribution. Is this realistic in the new interconnected, co-operative 
and fast-moving research world?
In the new regime of open science, with the need for rapid 
generation of results and free information sharing, we may need 
to revise the way in which a researcher is trained and a doctorate 
achieved. If we are seeking to develop high-level, transdisciplinary 
thinking that enables rapid progress in solving global questions, 
the ability to adapt to working creatively in a collaborative and 
interconnected way may be the most critical skill researchers need. 
The future leaders of research will be those who can most effectively 
draw together teams, and integrate thinking across boundaries, both 
spatial and disciplinary.
Clinician-scientists
Understanding the pathogenesis of human disease requires input 
from many sources, and this is particularly relevant in the context of 
the COVID-19 pandemic. From the perspective of the basic scientist, 
by working with cells and molecules, one obtains an understanding 
not only of the exacting nature of the science, but also of the extent 
of co-ordination and fidelity that is required for normal structure 
and function. From the perspective of the clinician, understanding 
the molecular and cellular basis of disease improves the quality of 
care. A close interaction between clinicians and scientists is desirable. 
Clinician-scientists, i.e. those who are active in both fields, are a rare 
breed. Yet in crisis situations, as exemplified by the current pandemic 
and those that are likely to follow, clinician-scientists are needed in 
order to understand disease pathogenesis and integrate knowledge 
from a variety of sources, to provide preventive and therapeutic 
solutions. COVID-19 has highlighted more than ever before the need 
to (re)initiate programmes that foster the growth of the clinician-
scientist workforce.[21]
Conclusions
The hardship and heartache caused by COVID-19 have led to 
new thinking on many levels, from the individual to the global. 
Research pace has been altered, investment in research has moved 
on its axis, and researchers have changed their focus. We must expect 
other pandemics in the future, and if we learn from the COVID-
19 experience, we will be able to take an informed and integrated 
approach to the research that will be needed.[22] A quote attributed to 
Charles Darwin (1809 - 1882) is pertinent in the current context: ‘It is 
not the strongest of the species that survives, nor the most intelligent 
that survives. It is the one that is the most adaptable to change.’ As 
our world undergoes dramatic changes in which the familiar becomes 
almost unrecognisable, the ability to adapt will become increasingly 
important, and nowhere is this more important than in the context of 
research, on which the survival of our species will ultimately depend.
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